SCHEMBL17119910

SCHEMBL17119910

O=CCc1c[nH]nc1-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.39
ALDH1A1 P00352 5/20 0.36
MAPT P10636 1/20 0.36
GFER P55789 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 4/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 3/20 0.34
GAA P10253 2/20 0.34
ALPL P05186 1/20 0.34
IDO1 P14902 1/20 0.34
TTK P33981 1/20 0.34
MAPK10 P53779 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
TP53 P04637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
AKT1 P31749 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7559397 0.83 ALOX15 (0.39) ALOX15ALDH1A1MAPTGFERKDM4E
SCHEMBL11123121 0.80 ALOX15 (0.43) ALOX15ALDH1A1MAPTGFERATM
SCHEMBL28312868 0.80 ALOX15 (0.37) ALOX15ALDH1A1MAPTGFERATM
SCHEMBL27518476 0.78 ALOX15 (0.35) ALOX15ALDH1A1MAPTGFERATM
SCHEMBL18901018 0.77 DPP4 (0.44) ALOX15ALDH1A1MAPTGFERATM
SCHEMBL28861332 0.77 ALOX15 (0.43) ALOX15ALDH1A1MAPTGFERATM
SCHEMBL28583866 0.77 ALOX15 (0.43) ALOX15ALDH1A1MAPTGFERATM
SCHEMBL5381933 0.76 KDM4E (0.49) ALOX15ALDH1A1MAPTKDM4ELMNA
SCHEMBL20449061 0.74 TAAR1 (0.41) ALOX15ALDH1A1MAPTGFERKDM4E
SCHEMBL14094653 0.74 RIPK1 (0.42) ALOX15ALDH1A1MAPTGFERATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150266864-A1 HETEROAROMATIC COMPOUNDS, METHOD FOR PREPARING THE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USES AND METHOD FOR TREATING ACUTE AND CHRONIC PAIN CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA (BR) 2015-09-24 US disclosed
US-20150266864-A1 HETEROAROMATIC COMPOUNDS, METHOD FOR PREPARING THE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USES AND METHOD FOR TREATING ACUTE AND CHRONIC PAIN CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA (BR) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266864-A1 HETEROAROMATIC COMPOUNDS, METHOD FOR PREPARING THE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USES AND METHOD FOR TREATING ACUTE AND CHRONIC PAIN TRPV1, AP1G1, INA ALOX15 261/4885ALDH1A1 306/4885MAPT 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.